Trinity Biotech PLC
NASDAQ:TRIB

Watchlist Manager
Trinity Biotech PLC Logo
Trinity Biotech PLC
NASDAQ:TRIB
Watchlist
Price: 1.2 USD 9.09% Market Closed
Market Cap: 23m USD

Intrinsic Value

The intrinsic value of one TRIB stock under the Base Case scenario is 4.24 USD. Compared to the current market price of 1.2 USD, Trinity Biotech PLC is Undervalued by 72%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TRIB Intrinsic Value
4.24 USD
Undervaluation 72%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Trinity Biotech PLC

What is Valuation History?
Ask AI Assistant
What other research platforms think about TRIB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TRIB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Trinity Biotech PLC.

Explain Valuation
Compare TRIB to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TRIB?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Trinity Biotech PLC

Current Assets 41.1m
Cash & Short-Term Investments 5.2m
Receivables 16.6m
Other Current Assets 19.4m
Non-Current Assets 62.2m
Long-Term Investments 2.5m
PP&E 4.6m
Intangibles 51.3m
Other Non-Current Assets 3.7m
Current Liabilities 32.1m
Accounts Payable 26.8m
Other Current Liabilities 5.3m
Non-Current Liabilities 106.4m
Long-Term Debt 98.3m
Other Non-Current Liabilities 8.1m
Efficiency

Free Cash Flow Analysis
Trinity Biotech PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Trinity Biotech PLC

Revenue
61.6m USD
Cost of Revenue
-40.1m USD
Gross Profit
21.4m USD
Operating Expenses
-37.5m USD
Operating Income
-16.1m USD
Other Expenses
-15.7m USD
Net Income
-31.8m USD
Fundamental Scores

TRIB Profitability Score
Profitability Due Diligence

Trinity Biotech PLC's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
ROE is Increasing
Healthy Gross Margin
40/100
Profitability
Score

Trinity Biotech PLC's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

TRIB Solvency Score
Solvency Due Diligence

Trinity Biotech PLC's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
28/100
Solvency
Score

Trinity Biotech PLC's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TRIB Price Targets Summary
Trinity Biotech PLC

There are no price targets for TRIB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for TRIB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one TRIB stock?

The intrinsic value of one TRIB stock under the Base Case scenario is 4.24 USD.

Is TRIB stock undervalued or overvalued?

Compared to the current market price of 1.2 USD, Trinity Biotech PLC is Undervalued by 72%.

Back to Top